http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 17 Jun 2026 18:04:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Li+Mingyu/26661183.html si-local-file:///var/storage/secattach/20260617/26661183.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Li+Mingyu/26661183.html Wed, 17 Jun 2026 18:04:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Li+Mingyu/26661183.html si-local-file:///var/storage/secattach/20260617/26661183.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Li+Mingyu/26661183.html Wed, 17 Jun 2026 18:04:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Li+Mingyu/26661183.html si-local-file:///var/storage/secattach/20260617/26661183.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Li+Mingyu/26661183.html Wed, 17 Jun 2026 18:04:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/26640898.html si-local-file:///var/storage/secattach/20260612/26640898.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/26640898.html Fri, 12 Jun 2026 16:12:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/26640898.html si-local-file:///var/storage/secattach/20260612/26640898.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/26640898.html Fri, 12 Jun 2026 16:12:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/26640898.html si-local-file:///var/storage/secattach/20260612/26640898.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/26640898.html Fri, 12 Jun 2026 16:12:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Press+Releases/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html <ul type="disc"><li style="text-align:justify;">Post-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol “SLBT”</li><li style="text-align:justify;">Transaction provides strategic capital to advance proprietary Gamma delta T cell-based &quot;off-the-shelf&quot; cellular therapies for solid tumor indications, including pancreatic and brain cancers</li><li style="text-align:justify;">Leadership team bolstered by seasoned executives and highly experienced independent directors to drive the next phase of clinical and commercial growth<br/></li></ul> <p align="justify">TAIPEI, Taiwan, June 12, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. (“SL Bio” or the “Company”), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies, today announced the http://www.streetinsider.com/Globe+Newswire/SL+BIO+Ltd.+and+Horizon+Space+Acquisition+II+Announce+Closing+of+Business+Combination+and+Listing+on+the+Nasdaq+Global+Market/26640211.html Fri, 12 Jun 2026 14:51:00 -0400 A.50205093 HSPT HSPTU O.00023293 O.69536842 SLBT http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Horizon+Space+Acquisitio++For%3A+Mar+31/26527292.html si-local-file:///var/storage/secattach/20260520/26527292.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Horizon+Space+Acquisitio++For%3A+Mar+31/26527292.html Wed, 20 May 2026 13:18:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Horizon+Space+Acquisitio++For%3A+Mar+31/26527292.html si-local-file:///var/storage/secattach/20260520/26527292.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Horizon+Space+Acquisitio++For%3A+Mar+31/26527292.html Wed, 20 May 2026 13:18:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Horizon+Space+Acquisitio++For%3A+Mar+31/26527292.html si-local-file:///var/storage/secattach/20260520/26527292.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Horizon+Space+Acquisitio++For%3A+Mar+31/26527292.html Wed, 20 May 2026 13:18:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Horizon+Space+Acquisitio++For%3A+Mar+31/26505837.html si-local-file:///var/storage/secattach/20260515/26505837.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Horizon+Space+Acquisitio++For%3A+Mar+31/26505837.html Fri, 15 May 2026 16:22:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Horizon+Space+Acquisitio++For%3A+Mar+31/26505837.html si-local-file:///var/storage/secattach/20260515/26505837.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Horizon+Space+Acquisitio++For%3A+Mar+31/26505837.html Fri, 15 May 2026 16:22:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Horizon+Space+Acquisitio++For%3A+Mar+31/26505837.html si-local-file:///var/storage/secattach/20260515/26505837.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Horizon+Space+Acquisitio++For%3A+Mar+31/26505837.html Fri, 15 May 2026 16:22:00 -0400 HSPT HSPTU O.69536842 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+MIZUHO+FINANCIAL+GROUP+INC/26489394.html si-local-file:///var/storage/secattach/20260514/26489394.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Horizon+Space+Acquisitio+++++++++++++++Filed+by%3A+MIZUHO+FINANCIAL+GROUP+INC/26489394.html Thu, 14 May 2026 06:27:00 -0400 HSPT HSPTU O.69536842